Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Big Data vs. Infectious Disease

Posted on October 20th, 2017 by in Pharma R&D

With the many highly effective vaccines that have been created over the last several decades, it can be easy (particularly for those in America and other developed countries) to fall into the trap of thinking that we are living in a world where infectious disease is not that big of a threat. (more…)

Pharma Companies United By a Need for Common Data Models

Posted on October 18th, 2017 by in Pharma R&D

There is nothing that pharmaceutical companies guard more fiercely than their intellectual property. Devising and patenting the next big wonder drug is every company’s dream (more…)

Snakes (aka Chutes) and Ladders – failures and opportunities

Posted on October 13th, 2017 by in Pharma R&D

If there ever was a children’s game that would help prepare the next generation of pharmaceutical R&D scientists and researchers, it would be Snakes and Ladders (Chutes and Ladders in the US). (more…)

Big Data and Proactive Pharmacovigilance

Posted on September 20th, 2017 by in Pharmacovigilance

Traditionally thought of as a post-market process, pharmacovigilance is how pharmaceutical companies monitor and address any safety issues that arise once a drug becomes available commercially. However, some companies are now thinking ahead about these potential safety concerns with what is known as “proactive PV”. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 6